Literature DB >> 1761084

Pharmacokinetics of flumazenil in fulminant hepatic failure.

C C van der Rijt, R H Drost, S W Schalm, M Schramel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1761084     DOI： 10.1007/BF00626380

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Improvement of hepatic encephalopathy treated with flumazenil.

Authors:  G Grimm; P Ferenci; R Katzenschlager; C Madl; B Schneeweiss; A N Laggner; K Lenz; A Gangl
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

2.  Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.

Authors:  G Roncari; W H Ziegler; T W Guentert
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction.

Authors:  G Pomier-Layrargues; J F Giguère; J Lavoie; B Willems; R F Butterworth
Journal:  Hepatology       Date:  1989-12       Impact factor: 17.425

4.  Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.

Authors:  U Klotz; G Ziegler; L Ludwig; I W Reimann
Journal:  J Clin Pharmacol       Date:  1985-09       Impact factor: 3.126

5.  Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.

Authors:  U Klotz; G Ziegler; I W Reimann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Flumazenil disposition and elimination in cirrhosis.

Authors:  U Janssen; S Walker; K Maier; U von Gaisberg; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1989-09       Impact factor: 6.875

7.  Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

Authors:  G Bansky; P J Meier; E Riederer; H Walser; W H Ziegler; M Schmid
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

8.  Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.

Authors:  U Klotz; T Duka; R Dorow; A Doenicke
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.